Navigation Links
West Penn Allegheny Health System Physicians Pinpoint Gastroesophageal Reflux Disease (GERD) as a Factor That May Cause Chronic Cough

Pittsburgh, PA (PRWEB) May 24, 2013

Patients who have chronic cough with no known cause may be more likely to suffer from gastroesophageal reflux disease or GERD, West Penn Allegheny Health System physicians reported in a study published today.

The article, “Antireflux Surgery in Patients with Chronic Cough and Abnormal Proximal Exposure as Measured by Hypopharyngeal Multichannel Intraluminal Impedance” appears in JAMA Surgery.

“These findings could be of great importance to individuals who live with a nagging cough without a known cause,” said Blair A. Jobe, MD, principal investigator of the study and Director of the Institute for the Treatment of Esophageal and Thoracic Disease at West Penn Allegheny Health System.

“Undergoing screening and, if applicable, treatment for GERD can not only improve patients’ quality of life by curbing chronic cough, it can also help prevent serious conditions such as Barrett’s esophagus and esophageal cancer.”

GERD occurs when the muscles at the end of the esophagus fail to properly close, allowing stomach contents to leak back or reflux into the esophagus, causing irritation. Common symptoms of GERD include heartburn, regurgitation, and tasting stomach acid in the back of the throat. Hoarseness, a feeling of having a “lump in your throat” and frequent throat clearing are lesser known symptoms of GERD.

The trial examined 314 patients who underwent testing with a specialized catheter to detect reflux and determined that 49 of them also had chronic cough, a persistent cough with no known cause lasting more than eight weeks. Of the patients with chronic cough, 52 percent were diagnosed with GERD.

“These patients did not display classic symptoms of GERD and may not have been diagnosed with conventional pH testing which measures the amount of stomach acid in the esophagus,” said Toshitaka Hoppo, MD, a general surgeon specializing in esophageal surgery who was involved in the trial.

For such patients, undergoing Hypopharyngeal Multichannel Intraluminal Impedance (HMII) testing is key to achieving a diagnosis. HMII is ideal for assessing the proximity of reflux events from the lower esophageal sphincter muscle regardless of their pH level.

Of the 49 patients with chronic cough in the study, 73 percent were found to have abnormal proximal exposure of reflux. Sixteen of those patients underwent antireflux surgery with 81 percent achieving resolution of their cough.

“Once GERD is diagnosed, many patients may benefit from antireflux surgery,” Dr. Jobe said. “The increased sensitivity of HMII testing enables us to properly diagnose patients who don’t display the telltale signs and symptoms of GERD, treat the underlying problem and prevent future complications while relieving their cough.”

Chronic cough is a condition that affects 8 to 12 percent of adults.

The Institute for the Treatment of Esophageal and Thoracic Disease at WPAHS is a comprehensive, multi-disciplinary program that focuses on the treatment of patients with lung cancer, mediastinal diseases, esophageal cancer, Barrett’s esophagus, hiatal hernia, esophageal motility disorders, gastroesophageal reflux disease, and swallowing issues.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. West Penn Allegheny Health System is First in Pennsylvania to Perform Groundbreaking Minimally-Invasive Procedure for Swallowing Disorder
2. Study by Allegheny General Hospital Physicians Shows Oral Immunotherapy is a Safe, Effective Alternative to Allergy Shots for Ragweed Sufferers
3. 2013 Alleged Zithromax Arrhythmia and Sudden Death Cases Update: Canadian Health Officials Issue Warning
4. Scott Tischler of Tischler Brothers Fitness Unveils the 7 Rules to a Healthy Diet
5. Dermasis Psoriasis Treatment Cream for Men and Women Released Online at
6. Susquehanna Health Offers Safe Sitter Course for Tweens and Teens
7. Netsmart Named to Healthcare Informatics Top 100 List
8. PilotFish Expand’s Healthcare Integration Capabilities with Support for the New Direct Protocol in Its Latest Product Release
9. Health2Go Announces Research That DHEA Helps Depression
10. DUXIANA®, Quality Bed Innovator, Celebrates Better Sleep Month and Launches Summer Health Campaign
11. Healthcare Internet Marketing Consulting Services Launched by JD Media Surge
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... ... philanthropic seniors, is resulting in a way for homeless people to have a ... have launched a new initiative whereby they are repurposing plastic bags into sleeping ...
(Date:11/25/2015)... ... 2015 , ... Many people know of the common symptoms of low thyroid ... skin. But many people who find their cholesterol levels and weight are creeping up ... especially if they don’t have any of the other symptoms. , Thyroid hormone plays ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... for Tuberous Sclerosis Complex (TSC), as well as raising public awareness of the ... they need it—presented a third donation of $35,000 to bolster progress at the ...
(Date:11/25/2015)... ... November 25, 2015 , ... Since its launch in ... involving adult stem cell therapies to patients with chronic degenerative medical conditions. Now, ... a Registered Trademark (RTM). , Organizations are required to hold a registered trademark ...
(Date:11/25/2015)... ... November 25, 2015 , ... Students and parents have something to ... of the Create Real Impact awards. California Casualty is proud to support ... tide of distracted and reckless driving, the number one killer of young drivers. ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... Israel , November 25, 2015 ... "New Investors"), pursuant to which BioLight and the New ... IOPtima Ltd. subsidiary ("IOPtima") via a private placement. The ... of its innovative IOPtimate™ system used in the treatment ... approval pathway process for the IOPtimate™ system with the ...
(Date:11/25/2015)... 25, 2015  Mindray Medical International ... MR ), a leading developer, manufacturer ... today announced that it will hold ... shareholders at the Company,s Hong Kong office (FLAT/RM ... Edward West Road, Mongkok KL, Hong Kong) ...
(Date:11/25/2015)... November 25, 2015 Developmental, commercial, ... boosting the profitability of pharmaceutical products, says GBI ... and regulatory/legal strategies all play a key role ... GBI Research . --> Developmental, ... key role in boosting the profitability of pharmaceutical products, ...
Breaking Medicine Technology: